Wednesday - July 16, 2025

Category Archives: Pharmaceuticals & Biotech

Duchenne Muscular Dystrophy Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Li

Duchenne Muscular Dystrophy Pipeline Analysis DelveInsight’s, “Duchenne Muscular Dystrophy – Pipeline Insight, 2025,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Duchenne Muscular Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Dry Age-Related Macular Degeneration Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuti

Dry Age-Related Macular Degeneration Pipeline Analysis DelveInsight’s, “Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2025” report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the pipeline drug profiles, … Continue reading →

Eczema Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun

Eczema Pipeline Analysis DelveInsight’s, “Eczema- Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Exosomes Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Miltenyi Biomedicine, Adicet Bio, VelosBio, Novartis Pharmaceuticals, Sanofi, Eisai Co,

Exosomes Pipeline Analysis DelveInsight’s, “Exosomes- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Exosomes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Head and Neck Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Debiopharm, Merck, GlaxoSmithKline, QBiotics Group Limited, Memgen, Inc

Head and Neck Cancer Pipeline Analysis DelveInsight’s, “Head and Neck cancer (HNC) – Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Head and Neck cancer (HNC) pipeline landscape. It covers the pipeline drug … Continue reading →

Heart Failure Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Mesoblast, Rivus Pharmaceuticals, Heartseed Inc, StemCardia, Eli Lilly and Com

Heart Failure Pipeline Analysis DelveInsight’s, “Heart Failure – Pipeline Insight, 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Heart Failure pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Hemophilia Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therap

Hemophilia Pipeline Analysis DelveInsight’s, “Hemophilia- Pipeline Insight, 2025,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Hepatic Tumor Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Developm

Hepatic Tumor Pipeline Insights DelveInsight’s, “Hepatic Tumor – Pipeline Insight, 2025,”report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Hepatic Tumor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

Liver Cirrhosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, Route of Administration, and Companies by DelveInsight

Liver Cirrhosis Clinical Trials Liver cirrhosis companies such as Versantis AG, Mirum Pharmaceuticals, Sagimet Biosciences, TenNor Therapeutics, Prism Pharma, Vedanta Biosciences, Lipocine, Gwo Xi Stem Cell Applied Technology, Galectin Therapeutics, Resolution Therapeutics, Ipsen, AstraZeneca, and others. (Albany, USA) DelveInsight’s ‘Liver … Continue reading →

Asherman’s Syndrome Market Set for Robust Growth Through 2032, Driven by Expanding Clinical Development Pipeline | DelveInsight

Asherman’s Syndrome Market Insight, Epidemiology And Market Forecast – 2032 The Asherman’s Syndrome market is experiencing notable expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players developing innovative treatments for this challenging condition. While … Continue reading →